Chemoinformaics analysis of trimethyl psoralen
| Molecular Weight | 228.247 | nRot | 0 |
| Heavy Atom Molecular Weight | 216.151 | nRig | 16 |
| Exact Molecular Weight | 228.079 | nRing | 3 |
| Solubility: LogS | -5.546 | nHRing | 2 |
| Solubility: LogP | 3.544 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 15 |
| nHA | 3 | APOL | 33.7875 |
| nHD | 0 | BPOL | 16.3785 |
| QED | 0.553 |
| Synth | 2.516 |
| Natural Product Likeliness | 0.28 |
| NR-PPAR-gamma | 0.015 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.975 |
| HIA | 0.008 |
| CACO-2 | -4.741 |
| MDCK | 0.0000198 |
| BBB | 0.023 |
| PPB | 0.841979 |
| VDSS | 0.746 |
| FU | 0.0865839 |
| CYP1A2-inh | 0.966 |
| CYP1A2-sub | 0.966 |
| CYP2c19-inh | 0.626 |
| CYP2c19-sub | 0.491 |
| CYP2c9-inh | 0.261 |
| CYP2c9-sub | 0.737 |
| CYP2d6-inh | 0.586 |
| CYP2d6-sub | 0.883 |
| CYP3a4-inh | 0.486 |
| CYP3a4-sub | 0.277 |
| CL | 11.448 |
| T12 | 0.442 |
| hERG | 0.003 |
| Ames | 0.099 |
| ROA | 0.092 |
| SkinSen | 0.221 |
| Carcinogencity | 0.895 |
| EI | 0.066 |
| Respiratory | 0.344 |
| NR-Aromatase | 0.884 |
| Antiviral | Yes |
| Prediction | 0.647481 |